Drugs and Cancer Propagation

  • Amit Prabhakar
  • Alan David Kaye
  • Richard D. Urman


Cancer is one of the most significant healthcare issues in both the developed and undeveloped world. The American Cancer Society projects that over 1,638,910 new cancer cases and over 577,190 cancer-related deaths will occur in the United States alone this year. The most prevalent cancers in the United States are breast, prostate, lung, and gastrointestinal, respectively.


Opioid Receptor Regional Anesthesia Epidural Anesthesia Postoperative Pain Control Paravertebral Block 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material


  1. 1.
    American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012.Google Scholar
  2. 2.
    Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther. 2004;11(5):354–65. Epub 2004/09/10.PubMedCrossRefGoogle Scholar
  3. 3.
    McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 2001;62(2):111–23. Epub 2001/03/14.PubMedCrossRefGoogle Scholar
  4. 4.
    Gupta K. Iatrogenic angiogenesis. In: Parat MO, editor. Morphine and metastasis. Dordrecht: Springer; 2013: chap 5.Google Scholar
  5. 5.
    Gupta M, Yunfang L, Gupta K. Opioids as promoters and regulators of angiogenesis. In: Maragoudakis ME, Papadimitriou E, editors. Angiogenesis: basic science and clinical applications. Kerala: Transworld Research Network. 2007; p. 303–17.Google Scholar
  6. 6.
    Borner C, Kraus J, Schroder H, Ammer H, Hollt V. Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6. Mol Pharmacol. 2004;66:1719–26.PubMedCrossRefGoogle Scholar
  7. 7.
    Snyder, Greenberg. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth. 2010;105(2):106–15.PubMedCrossRefGoogle Scholar
  8. 8.
    Koodie L, Roy S. Morphine and immunosuppression in the context of tumor growth and metastasis. In: Parat MO, editor. Morphine and metastasis. Dordrecht: Springer; 2013: chap 3.Google Scholar
  9. 9.
    Franchi S, Panerai AE, Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine and fentanyl treatment. Brain Behav Immun. 2007;21(6):767–74.Google Scholar
  10. 10.
    Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008;2(1):14–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Li W, Tang HZ, Jiang YB, Xu MX. Influence of different doses of fentanyl on T-lymphocyte and subpopulations and natural killer cells of patients with esophageal tumor during preoperation and postoperation. Ai Zheng. 2003;22(6):634–6.PubMedGoogle Scholar
  12. 12.
    Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97:1331–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Siddiqui RA, Zerouga M, Wu M, Castillo A, Harvey K, Zaloga GP, Stillwell W. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res. 2005;7:R645–54.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Markovic SN, Knight PR, Murasko DM. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology. 1993;78(4):700–6. Epub 1993/04/01.PubMedCrossRefGoogle Scholar
  15. 15.
    Hole A, Unsgaard G. The effect of epidural and general anaesthesia on lymphocyte functions during and after major orthopaedic surgery. Acta Anaesthesiol Scand. 1983;27(2):135–41. Epub 1983/04/01.PubMedCrossRefGoogle Scholar
  16. 16.
    Brand JM, Kirchner H, Poppe C, Schmucker P. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol. 1997;83:190–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Shilling AM, Mohamed T. Perioperative morphine and cancer recurrence. In: Parat MO, editor. Morphine and metastasis. Dordrecht: Springer; 2013: chap 9.Google Scholar
  18. 18.
    Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG, Buggy DJ. Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene. Br J Anaesth. 2011;107:916–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS. Presence of the mu3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J Biol Chem. 1995;270:30290–3.PubMedCrossRefGoogle Scholar
  20. 20.
    Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, Hebbel RP. Morphine stimulates angiogenesis by activating proangiogenic and survival promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62:4491–8.PubMedGoogle Scholar
  21. 21.
    Poonawala T, Levay-Young BK, Hebbel RP, Gupta K. Opioids heal ischemic wounds in the rat. Wound Repair Regen. 2005;13:165–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T. Role of prostaglandin e2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci. 2004;101:591–6.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW. Simultaneous inhibition of the receptor tyrosine kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Res. 2002;62:4491–8.Google Scholar
  24. 24.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. COX-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 2002;62:625–31.PubMedGoogle Scholar
  25. 25.
    Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer. 2007;97:1523–31.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Moore TM, Chetham PM, Kelly JJ, Stevens T. Signal transduction and regulation of lung endothelial cell permeability: interaction between calcium and cAMP. Am J Physiol. 1998;275:L203–22.PubMedGoogle Scholar
  27. 27.
    Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115:1363–81.PubMedCentralPubMedGoogle Scholar
  28. 28.
    Sharma SK, Nirenberg M, Klee WA. Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci. 1975;72:590–4.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Gintzler AR, Chakrabarti S. Post opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules. Life Sci. 2006;79:717–22.PubMedCrossRefGoogle Scholar
  30. 30.
    Koodie L, Ramakrishnan S, Roy S. Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol. 2010;177:984–97.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Shanahan H, Parat MO, Buggy D. Could opioids affect cancer recurrence or metastases? Current experimental and translational evidence. In: Parat MO, editor. Morphine and metastasis. Dordrecht: Springer; 2013: chap 6.Google Scholar
  32. 32.
    Macfarlane GJ, McBeth J, Silman AJ. Widespread body pain and mortality: prospective population based study. BMJ. 2001;323:662–5.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Sasamura T, Nakamura S, Lida Y, Fujii H, Murata J, Saiki I, Nojima H, Kuraishi Y. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol. 2002;441:185–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Stefanski V, Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol Behav. 1996;60:277–82.PubMedCrossRefGoogle Scholar
  36. 36.
    Andersen BL, Farrar WB, Golden-Kreutz D, Kutz LA, MacCallum R, Courtney ME, Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 1998;90:30–6.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Sessler DI. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev. 2008;17:269–72.PubMedCrossRefGoogle Scholar
  38. 38.
    O’Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg. 2005;100:244–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Moller JF, Nikolajsen L, Rodt SA, Ronning H, Carlsson PS. Thoracic paravertebral block for breast cancer surgery: a randomized double-blind study. Anesth Analg. 2007;105:1848–51.PubMedCrossRefGoogle Scholar
  40. 40.
    Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth Analg. 2007;104(6):1334–42, table of contents. Epub 2007/05/22.PubMedCrossRefGoogle Scholar
  41. 41.
    Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Hohne C, Fritz G, Keh D. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth. 2008;101(6):781–7. Epub 2008/10/17.PubMedCrossRefGoogle Scholar
  42. 42.
    Looney M, Doran P, Buggy DJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor beta in women undergoing anesthesia and surgery for breast cancer. Anesthesiology. 2010;113(5):1118–25.PubMedCrossRefGoogle Scholar
  43. 43.
    Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg. 2006;102:1103–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro. J Pharmacol Exp Ther. 1999;288:660–4.PubMedGoogle Scholar
  45. 45.
    de Oliveira Jr GS, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med. 2011;36(3):271–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008;109(2):180–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S, Pillay J, Finucane BT. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. J Can Anaesth. 2010;57(2):107–12.CrossRefGoogle Scholar
  48. 48.
    Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN, Studer UE, Stueber F, Burkhard FC. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology. 2010;113(3):570–6.PubMedGoogle Scholar
  49. 49.
    Forget P, Tombal B, Scholtes JL, Nzimbala J, Meulders C, Legrand C, Van Cangh P, Cosyns JP, De Kock M. Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol. 2011;28:830–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010;113(1):27–34.PubMedCrossRefGoogle Scholar
  51. 51.
    Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg. 2008;107(1):325–32.PubMedCrossRefGoogle Scholar
  52. 52.
    Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ. 2011;342:d1491.PubMedCrossRefGoogle Scholar
  53. 53.
    Schnabel A, Reichl SU, Kranke P, Pogatzki-Zahn EM, Zahn PK. Efficacy and safety of paravertebral blocks in breast surgery: a meta analysis of randomized controlled trials. Br J Anaesth. 2010;105:842–52.PubMedCrossRefGoogle Scholar
  54. 54.
    Wenk M, Schug SA. Perioperative pain management after thoracotomy. Curr Opin Anaesthesiol. 2011;24:8–12.PubMedCrossRefGoogle Scholar
  55. 55.
    Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105(4):660–4.PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat MO, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials. 2008;29(4):517–26.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Amit Prabhakar
    • 1
  • Alan David Kaye
    • 2
    • 1
  • Richard D. Urman
    • 3
    • 4
  1. 1.Department of AnesthesiologyLouisiana State University Health Sciences CenterNew OrleansUSA
  2. 2.Department of AnesthesiologyTulane Medical CenterNew OrleansUSA
  3. 3.Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  4. 4.Center for Perioperative Management and Medical Informatics, Brigham and Women’s HospitalBostonUSA

Personalised recommendations